GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Common Stock

Beximco Pharmaceuticals (DHA:BXPHARMA) Common Stock : BDT4,461 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Common Stock?

Beximco Pharmaceuticals's quarterly common stock stayed the same from Mar. 2023 (BDT4,461 Mil) to Jun. 2023 (BDT4,461 Mil) and stayed the same from Jun. 2023 (BDT4,461 Mil) to Dec. 2023 (BDT4,461 Mil).

Beximco Pharmaceuticals's annual common stock stayed the same from Jun. 2021 (BDT4,461 Mil) to Jun. 2022 (BDT4,461 Mil) and stayed the same from Jun. 2022 (BDT4,461 Mil) to Jun. 2023 (BDT4,461 Mil).

Beximco Pharmaceuticals Common Stock Historical Data

The historical data trend for Beximco Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Common Stock Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,055.56 4,055.56 4,461.12 4,461.12 4,461.12

Beximco Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,461.12 4,461.12 4,461.12 4,461.12 4,461.12

Beximco Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Common Stock
Comparable Companies
DHA:BEACONPHAR DHA:ACMELAB DHA:RENATA DHA:ORIONINFU DHA:ASIATICLAB DHA:CENTRALPHL DHA:SQURPHARMA ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB
Traded in Other Exchanges
BXP:UK R2WA:Germany
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Website
https://www.beximcopharma.com
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines